Gene: COL13A1 (collagen type XIII alpha 1 chain) Homo sapiens
Analyze
Symbol:
COL13A1
Name:
collagen type XIII alpha 1 chain
Description:
Exhibits heparin binding activity. Involved in cell-cell adhesion and cell-matrix adhesion. Localizes to the collagen-containing extracellular matrix. Implicated in congenital myasthenic syndrome 19.
Type:
protein-coding
RefSeq Status:
REVIEWED
Also known as:
CMS19; collagen alpha-1(XIII) chain; collagen type XIII alpha 1; collagen, type XIII, alpha 1; COLXIIIA1; FLJ42485
Orthologs:
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Mus musculus (house mouse):
Col13a1 (collagen, type XIII, alpha 1)
HGNC
EggNOG, Ensembl, HGNC, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther, PhylomeDB, Treefam
Rattus norvegicus (Norway rat):
Col13a1 (collagen type XIII alpha 1 chain)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Chinchilla lanigera (long-tailed chinchilla):
Col13a1 (collagen type XIII alpha 1 chain)
NCBI
Ortholog
Pan paniscus (bonobo/pygmy chimpanzee):
COL13A1 (collagen type XIII alpha 1 chain)
NCBI
Ortholog
Canis lupus familiaris (dog):
COL13A1 (collagen type XIII alpha 1 chain)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Col13a1 (collagen type XIII alpha 1 chain)
NCBI
Ortholog
Sus scrofa (pig):
COL13A1 (collagen type XIII alpha 1 chain)
HGNC
EggNOG, Ensembl, NCBI, OMA, OrthoDB, Panther
Alliance orthologs 3
Mus musculus (house mouse):
Col13a1 (collagen, type XIII, alpha 1)
Alliance
DIOPT (Ensembl Compara, HGNC, Hieranoid, InParanoid, OMA, OrthoFinder, OrthoInspector, PANTHER, PhylomeDB, Roundup, TreeFam)
Rattus norvegicus (Norway rat):
Col13a1 (collagen type XIII alpha 1 chain)
Alliance
DIOPT (Ensembl Compara, HGNC, OMA, OrthoFinder, PANTHER)
Danio rerio (zebrafish):
col13a1 (collagen, type XIII, alpha 1)
Alliance
DIOPT (OrthoFinder, ZFIN)
Drosophila melanogaster (fruit fly):
CG42342
Alliance
DIOPT (Ensembl Compara, Hieranoid, InParanoid, PhylomeDB)
Caenorhabditis elegans (roundworm):
col-99
Alliance
DIOPT (Ensembl Compara, Hieranoid, OMA)
Allele / Splice:
See ClinVar data
Latest Assembly:
GRCh38 - Human Genome Assembly GRCh38
Position:
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 10 69,801,835 - 69,959,144 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh37 10 71,561,644 - 71,718,904 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 10 71,231,650 - 71,388,909 (+) NCBI NCBI36 hg18 NCBI36 Celera 10 64,838,564 - 64,996,131 (+) NCBI Cytogenetic Map 10 q22.1 NCBI HuRef 10 65,553,122 - 65,710,673 (+) NCBI HuRef CHM1_1 10 71,843,392 - 72,000,665 (+) NCBI CHM1_1
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Annotations - CTD
congenital myasthenic syndrome EXP 11554173 CTD Direct Evidence: marker/mechanism CTD Spontaneous Abortions EXP 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:18539642
Imported Annotations - OMIM
congenital myasthenic syndrome 19 IAGP 7240710 OMIM
17alpha-ethynylestradiol multiple interactions ISO RGD:1312682 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL13A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of COL13A1 mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of COL13A1 mRNA CTD PMID:20660070 , PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of COL13A1 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1312682 6480464 Tetrachlorodibenzodioxin affects the expression of COL13A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1312682 6480464 Tetrachlorodibenzodioxin results in increased expression of COL13A1 mRNA CTD PMID:16120747 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1312682 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of COL13A1 mRNA CTD PMID:17942748 4,4'-diaminodiphenylmethane increases expression ISO RGD:1312682 6480464 4, 4'-diaminodiphenylmethane results in increased expression of COL13A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1312682 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of COL13A1 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of COL13A1 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression ISO RGD:1595704 6480464 Propylthiouracil results in decreased expression of COL13A1 mRNA CTD PMID:24780913 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of COL13A1 intron CTD PMID:30157460 aflatoxin B2 increases methylation EXP 6480464 aflatoxin B2 results in increased methylation of COL13A1 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1312682 6480464 Tretinoin results in increased expression of COL13A1 mRNA CTD PMID:16604517 all-trans-retinoic acid decreases expression EXP 6480464 Tretinoin results in decreased expression of COL13A1 mRNA CTD PMID:23830798 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of COL13A1 mRNA CTD PMID:23724009 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of COL13A1 mRNA CTD PMID:20064835 benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of COL13A1 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:1312682 6480464 Benzo(a)pyrene results in increased expression of COL13A1 mRNA CTD PMID:22610609 benzo[a]pyrene affects expression EXP 6480464 Benzo(a)pyrene affects the expression of COL13A1 mRNA CTD PMID:22316170 benzo[e]pyrene affects methylation EXP 6480464 benzo(e)pyrene affects the methylation of COL13A1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of COL13A1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO RGD:1595704 6480464 bisphenol A results in decreased expression of COL13A1 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1312682 6480464 bisphenol A results in increased expression of COL13A1 mRNA CTD PMID:30951980 bisphenol A increases methylation ISO RGD:1595704 6480464 bisphenol A results in increased methylation of COL13A1 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:1312682 6480464 bisphenol F results in increased expression of COL13A1 mRNA CTD PMID:30951980 butanal increases expression EXP 6480464 butyraldehyde results in increased expression of COL13A1 mRNA CTD PMID:26079696 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of COL13A1 mRNA CTD PMID:16002434 , PMID:26485663 ciguatoxin CTX1B affects expression ISO RGD:1312682 6480464 Ciguatoxins affects the expression of COL13A1 mRNA CTD PMID:18353800 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of COL13A1 mRNA CTD PMID:19561079 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of COL13A1 mRNA CTD PMID:23300844 cobalt dichloride decreases expression ISO RGD:1595704 6480464 cobaltous chloride results in decreased expression of COL13A1 mRNA CTD PMID:24386269 cobalt dichloride multiple interactions EXP 6480464 cobaltous chloride promotes the reaction [HIF1A protein binds to COL13A1 gene] more ... CTD PMID:30381462 cytarabine decreases expression EXP 6480464 Cytarabine results in decreased expression of COL13A1 mRNA CTD PMID:21198554 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of COL13A1 mRNA CTD PMID:25047013 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of COL13A1 mRNA CTD PMID:26516004 dioxygen multiple interactions EXP 6480464 TP53 protein mutant form promotes the reaction [Oxygen deficiency results in increased expression of COL13A1 mRNA] CTD PMID:30381462 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of COL13A1 mRNA CTD PMID:30381462 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of COL13A1 mRNA CTD PMID:29803840 entinostat increases expression EXP 6480464 entinostat results in increased expression of COL13A1 mRNA CTD PMID:26272509 entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL13A1 mRNA CTD PMID:27188386 irinotecan increases expression EXP 6480464 Irinotecan analog results in increased expression of COL13A1 mRNA CTD PMID:18927307 isoflavones affects expression EXP 6480464 Isoflavones affects the expression of COL13A1 mRNA CTD PMID:16365062 lead diacetate decreases expression ISO RGD:1595704 6480464 lead acetate results in decreased expression of COL13A1 mRNA CTD PMID:11578147 lithium chloride decreases expression EXP 6480464 Lithium Chloride results in decreased expression of COL13A1 mRNA CTD PMID:23527032 methapyrilene affects methylation EXP 6480464 Methapyrilene affects the methylation of COL13A1 intron CTD PMID:30157460 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of COL13A1 mRNA CTD PMID:23179753 mifepristone decreases expression ISO RGD:1595704 6480464 Mifepristone results in decreased expression of COL13A1 mRNA CTD PMID:25972201 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of COL13A1 mRNA CTD PMID:16510598 paracetamol affects expression ISO RGD:1312682 6480464 Acetaminophen affects the expression of COL13A1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of COL13A1 mRNA CTD PMID:22230336 pentanal increases expression EXP 6480464 pentanal results in increased expression of COL13A1 mRNA CTD PMID:26079696 pentane-2,3-dione decreases expression ISO RGD:1595704 6480464 2, 3-pentanedione results in decreased expression of COL13A1 mRNA CTD PMID:25710175 phenylmercury acetate decreases expression EXP 6480464 Phenylmercuric Acetate results in decreased expression of COL13A1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of COL13A1 mRNA CTD PMID:27188386 potassium dichromate increases expression ISO RGD:1312682 6480464 Potassium Dichromate results in increased expression of COL13A1 mRNA CTD PMID:23608068 progesterone multiple interactions EXP 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of COL13A1 mRNA CTD PMID:20660070 propanal increases expression EXP 6480464 propionaldehyde results in increased expression of COL13A1 mRNA CTD PMID:26079696 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression EXP 6480464 Silicon Dioxide analog results in increased expression of COL13A1 mRNA CTD PMID:25895662 simvastatin decreases response to substance EXP 6480464 COL13A1 SNP results in decreased susceptibility to Simvastatin CTD PMID:21483694 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of COL13A1 mRNA CTD PMID:20371982 Soman increases expression ISO RGD:1595704 6480464 Soman results in increased expression of COL13A1 mRNA CTD PMID:19281266 tert-butyl hydroperoxide increases expression EXP 6480464 tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA CTD PMID:15336504 titanium dioxide multiple interactions EXP 6480464 [Vitallium analog binds to titanium dioxide] which results in decreased expression of COL13A1 mRNA CTD PMID:23825117 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of COL13A1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL13A1 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1312682 6480464 trimellitic anhydride results in decreased expression of COL13A1 mRNA CTD PMID:19042947 valproic acid decreases methylation EXP 6480464 Valproic Acid results in decreased methylation of COL13A1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1312682 6480464 Valproic Acid affects the expression of COL13A1 mRNA CTD PMID:17963808 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of COL13A1 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of COL13A1 mRNA CTD PMID:23179753 , PMID:25192806 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of COL13A1 mRNA CTD PMID:26272509 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL13A1 mRNA CTD PMID:27188386 vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL13A1 mRNA CTD PMID:27188386